{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:33:21Z","timestamp":1787924001056,"version":"build-2784847793"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2019ZX09201001-003-008"],"award-info":[{"award-number":["2019ZX09201001-003-008"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004921","name":"Shanghai Jiao Tong University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32070722"],"award-info":[{"award-number":["32070722"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.biopha.2024.117737","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T03:28:18Z","timestamp":1733714898000},"page":"117737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["An anti-RAGE chimeric antibody alleviates CCl4-induced liver fibrosis via RAGE\/NF-kB pathway in mice"],"prefix":"10.1016","volume":"181","author":[{"given":"Jing","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhedong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pameila","family":"Paerhati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixia","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5262-8447","authenticated-orcid":false,"given":"Yunsheng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2024.117737_bib1","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/hep.30969","article-title":"Is the total amount as important as localization and type of collagen in liver fibrosis attributable to steatohepatitis?","volume":"71","author":"Karsdal","year":"2020","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biopha.2024.117737_bib2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/apt.15773","article-title":"Review article: the signalling and functional role of the extracellular matrix in the development of liver fibrosis","volume":"52","author":"Villesen","year":"2020","journal-title":"Aliment Pharm. Ther."},{"key":"10.1016\/j.biopha.2024.117737_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2017.05.016","article-title":"Pathophysiology of liver fibrosis and the methodological barriers to the development of anti-fibrogenic agents","volume":"121","author":"Bottcher","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.biopha.2024.117737_bib4","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"group NNc. A multisociety delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.biopha.2024.117737_bib5","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1053\/j.gastro.2018.11.001","article-title":"Genomic medicine and implications for hepatocellular carcinoma prevention and therapy","volume":"156","author":"Dhanasekaran","year":"2019","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.biopha.2024.117737_bib6","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3350\/cmh.2017.0078","article-title":"Histopathological evaluation of liver fibrosis and cirrhosis regression","volume":"23","author":"Lo","year":"2017","journal-title":"Clin. Mol. Hepatol."},{"issue":"4","key":"10.1016\/j.biopha.2024.117737_bib7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/aja.1001320404","article-title":"Sternzellen\" in the liver: Perisinusoidal cells with special reference to storage of vitamin a","volume":"132","author":"Wake","year":"1971","journal-title":"Am. J. Anat."},{"issue":"48","key":"10.1016\/j.biopha.2024.117737_bib8","doi-asserted-by":"crossref","first-page":"10512","DOI":"10.3748\/wjg.v22.i48.10512","article-title":"Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets","volume":"22","author":"Zhang","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"11","key":"10.1016\/j.biopha.2024.117737_bib9","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1113\/JP281135","article-title":"When healing turns into killing - the pathophysiology of pancreatic and hepatic fibrosis","volume":"600","author":"Ferdek","year":"2022","journal-title":"J. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2024.117737_bib10","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1172\/JCI1018","article-title":"Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors","volume":"102","author":"Iredale","year":"1998","journal-title":"J. Clin. Invest"},{"issue":"24","key":"10.1016\/j.biopha.2024.117737_bib11","doi-asserted-by":"crossref","first-page":"9448","DOI":"10.1073\/pnas.1201840109","article-title":"Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis","volume":"109","author":"Kisseleva","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.biopha.2024.117737_bib12","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2012.06.036","article-title":"Deactivation of hepatic stellate cells during liver fibrosis resolution in mice","volume":"143","author":"Troeger","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2024.117737_bib13","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.redox.2013.12.016","article-title":"Role of advanced glycation end products in cellular signaling","volume":"2","author":"Ott","year":"2014","journal-title":"Redox Biol."},{"issue":"6","key":"10.1016\/j.biopha.2024.117737_bib14","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1002\/jcp.22492","article-title":"Involvement of membrane type 1-matrix metalloproteinase (MT1-MMP) in RAGE activation signaling pathways","volume":"226","author":"Kamioka","year":"2011","journal-title":"J. Cell Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2024.117737_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034698","article-title":"RAGE expression in human T cells: a link between environmental factors and adaptive immune responses","volume":"7","author":"Akirav","year":"2012","journal-title":"Plos One"},{"issue":"6","key":"10.1016\/j.biopha.2024.117737_bib16","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/10409238.2020.1819194","article-title":"RAGE and its ligands: from pathogenesis to therapeutics","volume":"55","author":"Jangde","year":"2020","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.biopha.2024.117737_bib17","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1749-6632.2011.06320.x","article-title":"Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications","volume":"1243","author":"Ramasamy","year":"2011","journal-title":"Ann. N. Y Acad. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2024.117737_bib18","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.neurobiolaging.2009.04.016","article-title":"Advanced glycation endproducts and their receptor RAGE in alzheimer's disease","volume":"32","author":"Srikanth","year":"2011","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.biopha.2024.117737_bib19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4149\/neo_2015_061","article-title":"RAGE and its ligands in cancer - culprits, biomarkers, or therapeutic targets","volume":"62","author":"Tesarova","year":"2015","journal-title":"Neoplasma"},{"key":"10.1016\/j.biopha.2024.117737_bib20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev-med-041316-085215","article-title":"Targeting RAGE signaling in inflammatory disease","volume":"69","author":"Hudson","year":"2018","journal-title":"Annu Rev. Med"},{"issue":"7","key":"10.1016\/j.biopha.2024.117737_bib21","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0092-8674(00)80801-6","article-title":"RAGE mediates a novel proinflammatory axis: a central\u00a0cell surface receptor for S100\/calgranulin polypeptides","volume":"97","author":"Hofmann","year":"1999","journal-title":"Cell"},{"issue":"6894","key":"10.1016\/j.biopha.2024.117737_bib22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature00858","article-title":"Release of chromatin protein HMGB1 by necrotic cells triggers inflammation","volume":"418","author":"Scaffidi","year":"2002","journal-title":"Nature"},{"issue":"43","key":"10.1016\/j.biopha.2024.117737_bib23","doi-asserted-by":"crossref","first-page":"25752","DOI":"10.1074\/jbc.270.43.25752","article-title":"The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system","volume":"270","author":"Hori","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2024.117737_bib24","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.4049\/jimmunol.1002253","article-title":"Septic shock is associated with receptor for advanced glycation end products ligation of LPS","volume":"186","author":"Yamamoto","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2024.117737_bib25","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1099\/vir.0.049254-0","article-title":"RAGE inhibits human respiratory syncytial virus syncytium formation by interfering with F-protein function","volume":"94","author":"Tian","year":"2013","journal-title":"J. Gen. Virol."},{"issue":"14","key":"10.1016\/j.biopha.2024.117737_bib26","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2021.36.e90","article-title":"Increased expression of S100B and RAGE in a mouse model of bile duct ligation-induced liver fibrosis","volume":"36","author":"Park","year":"2021","journal-title":"J. Korean Med Sci."},{"key":"10.1016\/j.biopha.2024.117737_bib27","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/917108","article-title":"The receptor for advanced glycation end products (RAGE) and the lung","volume":"2010","author":"Buckley","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"issue":"3","key":"10.1016\/j.biopha.2024.117737_bib28","first-page":"178","article-title":"the changes of advanced glycation end products in a rat liver fibrosis model and the interventional effect of aminoguanidin","volume":"14","author":"Gao","year":"2006","journal-title":"Zhonghua Gan Zang Bing. Za Zhi"},{"issue":"11","key":"10.1016\/j.biopha.2024.117737_bib29","first-page":"1217","article-title":"Significance of P53 and high mobility group box 1 protein in different levels of liver fibrosis in chronic hepatitis B. Zhong Nan Da Xue","volume":"40","author":"Li","year":"2015","journal-title":"Xue Bao Yi Xue Ban."},{"issue":"6","key":"10.1016\/j.biopha.2024.117737_bib30","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1002\/hep.30093","article-title":"High mobility group box-1 drives fibrosis progression signaling via the receptor for advanced glycation end products in mice","volume":"68","author":"Ge","year":"2018","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.biopha.2024.117737_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-021-03750-4","article-title":"Knockout RAGE alleviates cardiac fibrosis through repressing endothelial-to-mesenchymal transition (EndMT) mediated by autophagy","volume":"12","author":"Zhang","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.biopha.2024.117737_bib32","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3892\/mmr.2014.2207","article-title":"Anti-fibrotic effects of specific-siRNA targeting of the receptor for advanced glycation end products in a rat model of experimental hepatic fibrosis","volume":"10","author":"Cai","year":"2014","journal-title":"Mol. Med Rep."},{"key":"10.1016\/j.biopha.2024.117737_bib33","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejphar.2016.03.017","article-title":"Therapeutic effects of antigen affinity-purified polyclonal anti-receptor of advanced glycation end-product (RAGE) antibodies on cholestasis-induced liver injury in rats","volume":"779","author":"Xia","year":"2016","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2024.117737_bib34","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3389\/fnagi.2017.00337","article-title":"Cilostazol suppresses abeta-induced neurotoxicity in sh-sy5y cells through inhibition of oxidative stress and MAPK signaling pathway","volume":"9","author":"Oguchi","year":"2017","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.biopha.2024.117737_bib35","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/978-1-62703-230-8_15","article-title":"RAGE-mediated cell signaling","volume":"963","author":"Rouhiainen","year":"2013","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117737_bib36","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/gut.2004.042127","article-title":"Human hepatic stellate cell lines, lx-1 and lx-2: new tools for analysis of hepatic fibrosis","volume":"54","author":"Xu","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2024.117737_bib37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/0-387-24180-9_5","article-title":"Nf-kappab, an evolutionarily conserved mediator of immune and inflammatory responses","volume":"560","author":"Xiao","year":"2005","journal-title":"Adv. Exp. Med Biol."},{"issue":"13","key":"10.1016\/j.biopha.2024.117737_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27134275","article-title":"Progress and prospects of non-canonical nf-kappab signaling pathway in the regulation of liver diseases","volume":"27","author":"Tao","year":"2022","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.biopha.2024.117737_bib39","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/hep.27348","article-title":"Mouse hepatocyte overexpression of nf-kappab-inducing kinase (nik) triggers fatal macrophage-dependent liver injury and fibrosis","volume":"60","author":"Shen","year":"2014","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.biopha.2024.117737_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20112700","article-title":"ERK pathway in activated, myofibroblast-like, hepatic stellate cells: a critical signaling crossroad sustaining liver fibrosis","volume":"20","author":"Foglia","year":"2019","journal-title":"Int J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2024.117737_bib41","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1165\/rcmb.2007-0244OC","article-title":"KT. Loss of RAGE in pulmonary fibrosis - molecular relations to functional changes in pulmonary cell types","volume":"39","author":"Queisser","year":"2008","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117737_bib42","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/1097-4644(20010401)81:1<102::AID-JCB1027>3.0.CO;2-Y","article-title":"Role of receptor for advanced glycation end-product (RAGE) and the JAK\/STAT-signaling pathway in AGE-induced collagen production in nrk-49f cells","volume":"81","author":"Huang","year":"2001","journal-title":"J. Cell. Biochem."},{"issue":"12","key":"10.1016\/j.biopha.2024.117737_bib43","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1172\/JCI11951","article-title":"Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)","volume":"108","author":"Oldfield","year":"2001","journal-title":"J. Clin. Investig."},{"issue":"7","key":"10.1016\/j.biopha.2024.117737_bib44","doi-asserted-by":"crossref","DOI":"10.1093\/glycob\/cwi053","article-title":"Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation","volume":"15","author":"Ramasamy","year":"2005","journal-title":"Glycobiology"},{"issue":"5","key":"10.1016\/j.biopha.2024.117737_bib45","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1053\/jhep.2001.28788","article-title":"Up-regulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts","volume":"34","author":"Fehrenbach","year":"2001","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.biopha.2024.117737_bib46","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.bbadis.2014.06.017","article-title":"Involvement of the nuclear high mobility group b1 peptides released from injured hepatocytes in murine hepatic fibrogenesis","volume":"1842","author":"Kao","year":"2014","journal-title":"Biochim Biophys. Acta"},{"issue":"621","key":"10.1016\/j.biopha.2024.117737_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf7084","article-title":"Small-molecule antagonism of the interaction of the RAGE cytoplasmic domain with diaph1 reduces diabetic complications in mice","volume":"13","author":"Manigrasso","year":"2021","journal-title":"Sci. Transl. Med"},{"issue":"1","key":"10.1016\/j.biopha.2024.117737_bib48","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007566","article-title":"Uremic advanced glycation end products and protein-bound solutes induce endothelial dysfunction through suppression of kruppel-like factor 2","volume":"7","author":"Saum","year":"2018","journal-title":"J. Am. Heart Assoc."},{"issue":"3","key":"10.1016\/j.biopha.2024.117737_bib49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117737_bib50","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.molmed.2023.10.005","article-title":"Three 'e' challenges for siRNA drug development","volume":"30","author":"Guo","year":"2024","journal-title":"Trends Mol. Med"},{"key":"10.1016\/j.biopha.2024.117737_bib51","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.yjmcc.2021.06.003","article-title":"Epigenetic alterations of tgfbeta and its main canonical signaling mediators in the context of cardiac fibrosis","volume":"159","author":"Algeciras","year":"2021","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.biopha.2024.117737_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121713","article-title":"RAGE pathways play an important role in regulation of organ fibrosis","volume":"323","author":"Liu","year":"2023","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.biopha.2024.117737_bib53","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.apsb.2018.01.008","article-title":"Targeting ERK, an achilles' heel of the MAPK pathway, in cancer therapy","volume":"8","author":"Liu","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"issue":"8","key":"10.1016\/j.biopha.2024.117737_bib54","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.bbamcr.2006.11.010","article-title":"ERK implication in cell cycle regulation","volume":"1773","author":"Chambard","year":"2007","journal-title":"Biochim Biophys. Acta"},{"issue":"1","key":"10.1016\/j.biopha.2024.117737_bib55","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"Nf-kappab in biology and targeted therapy: New insights and translational implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"issue":"153","key":"10.1016\/j.biopha.2024.117737_bib56","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2001212","article-title":"The mammalian MAPK\/ERK pathway exhibits properties of a negative feedback amplifier","volume":"3","author":"Sturm","year":"2010","journal-title":"Sci. Signal"},{"issue":"2","key":"10.1016\/j.biopha.2024.117737_bib57","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.molcel.2004.11.055","article-title":"Regulation of raf-1 by direct feedback phosphorylation","volume":"17","author":"Dougherty","year":"2005","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.biopha.2024.117737_bib58","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/JLB.3MR0121-277R","article-title":"HMGB1: an overview of its roles in the pathogenesis of liver disease","volume":"110","author":"Ni","year":"2021","journal-title":"J. Leukoc. Biol."},{"issue":"5","key":"10.1016\/j.biopha.2024.117737_bib59","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.3892\/mmr.2017.6364","article-title":"HMGB1 induces lung fibroblast to myofibroblast differentiation through NF-\u03baB-mediated TGF-\u03b21 release","volume":"15","author":"Wang","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2024.117737_bib60","article-title":"High mobility group box-1 promotes the proliferation and migration of hepatic stellate cells via tlr4-dependent signal pathways of pi3k\/akt and jnk","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"issue":"15","key":"10.1016\/j.biopha.2024.117737_bib61","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1042\/CS20180177","article-title":"HMGB1-induced autophagy facilitates hepatic stellate cells activation: a new pathway in liver fibrosis","volume":"132","author":"Li","year":"2018","journal-title":"Clin. Sci. (Lond. )"},{"issue":"4","key":"10.1016\/j.biopha.2024.117737_bib62","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jhep.2013.11.033","article-title":"Dietary glycotoxins exacerbate progression of experimental fatty liver disease","volume":"60","author":"Leung","year":"2014","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.biopha.2024.117737_bib63","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jhep.2011.07.028","article-title":"Endogenous formation of nepsilon-(carboxymethyl)lysine is increased in fatty livers and induces inflammatory markers in an in vitro model of hepatic steatosis","volume":"56","author":"Gaens","year":"2012","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.biopha.2024.117737_bib64","first-page":"4320","article-title":"AGER1 downregulation associates with fibrosis in nonalcoholic steatohepatitis and type 2 diabetes","volume":"130","author":"Dehnad","year":"2020","journal-title":"J. Clin. Invest"},{"issue":"1","key":"10.1016\/j.biopha.2024.117737_bib65","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-33661-y","article-title":"RAGE deficiency does not affect non-alcoholic steatohepatitis and atherosclerosis in western type diet-fed ldlr(-\/-) mice","volume":"8","author":"Bijnen","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2024.117737_bib66","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96859-7","article-title":"Deletion of RAGE fails to prevent hepatosteatosis in obese mice due to impairment of other AGEs receptors and detoxifying systems","volume":"11","author":"Wouters","year":"2021","journal-title":"Sci. Rep."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224016238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224016238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:06:04Z","timestamp":1787922364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224016238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":66,"alternative-id":["S0753332224016238"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117737","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An anti-RAGE chimeric antibody alleviates CCl4-induced liver fibrosis via RAGE\/NF-kB pathway in mice","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117737","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117737"}}